| Mrs Antoinette Eva Oberriter, PHARMD | |
|
11290 Donner Pass Rd, Truckee, CA 96161-4808 | |
| (530) 582-7952 | |
| (530) 582-7965 |
| Full Name | Mrs Antoinette Eva Oberriter |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 11290 Donner Pass Rd, Truckee, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124321435 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 49919 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Antoinette Eva Oberriter, PHARMD 11290 Donner Pass Rd, Truckee, CA 96161-4808 Ph: (530) 582-7952 | Mrs Antoinette Eva Oberriter, PHARMD 11290 Donner Pass Rd, Truckee, CA 96161-4808 Ph: (530) 582-7952 |
News Archive
Covidien, a leading global provider of healthcare products, announced that its hernia and abdominal wall repair products were featured in 18 podium presentations at the 32nd International Congress of the European Hernia Society (EHS).
The American College of Physicians, expressed support for some of the provisions included in the final rules for the Medicare Physician Fee Schedule and the Quality Payment Program for 2018, and noted some areas of concern in the rules that were released by the Centers for Medicare and Medicaid Services on Nov. 2.
Information gathered from routine visits to the doctor is enough to accurately predict a person's risk of developing Alzheimer's disease and related dementias, according to new research led by scientists from Regenstrief Institute, Indiana University and Merck.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.
› Verified 2 days ago
Dr. Donna Jeanne Sundale, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10038 Meadow Way, Suite D, Truckee, CA 96161 Phone: 530-587-2273 Fax: 530-587-2982 | |
Calvin Mayo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11230 Donner Pass Rd, Truckee, CA 96161 Phone: 530-587-5296 | |
Mr. Daniel Mark Colby, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11230 Donner Pass Rd, Truckee, CA 96161 Phone: 530-587-5296 | |
Mrs. Lael Wan Patrick, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10956 Donner Pass Rd Ste 100, Truckee, CA 96161 Phone: 530-587-7607 Fax: 530-587-6771 | |
Faheem Baki, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11230 Donner Pass Rd, Truckee, CA 96161 Phone: 530-587-5296 | |
Hilary S Ward, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10121 Pine Ave, Tahoe Forest Hospital Inpatient Pharmacy, Truckee, CA 96161 Phone: 530-582-3430 |